210 related articles for article (PubMed ID: 33302222)
21. Report and literature review of four cases of EWSR1::NFATC2 round cell sarcoma.
Liu L; Li L; Ding Y; Kong F; Mo W; Ye H; Shen D
Diagn Pathol; 2024 Jan; 19(1):19. PubMed ID: 38254207
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of routine histology, immunohistochemistry, reverse transcriptase polymerase chain reaction, and fluorescence in situ hybridization in diagnosis of Ewing family of tumors.
Jambhekar NA; Bagwan IN; Ghule P; Shet TM; Chinoy RF; Agarwal S; Joshi R; Amare Kadam PS
Arch Pathol Lab Med; 2006 Dec; 130(12):1813-8. PubMed ID: 17149955
[TBL] [Abstract][Full Text] [Related]
23. OLIG2 Immunolabeling of Mesenchymal Chondrosarcoma: Report of 14 Cases.
Yao K; Duan Z; Yang S; Du Z; Wang Y; Qi X
J Neuropathol Exp Neurol; 2020 Sep; 79(9):959-965. PubMed ID: 32770197
[TBL] [Abstract][Full Text] [Related]
24. Mesenchymal chondrosarcomas showing immunohistochemical evidence of rhabdomyoblastic differentiation: a potential diagnostic pitfall.
Folpe AL; Graham RP; Martinez A; Schembri-Wismayer D; Boland J; Fritchie KJ
Hum Pathol; 2018 Jul; 77():28-34. PubMed ID: 29559236
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic utility of cyclin D1 in the diagnosis of small round blue cell tumors in children and adolescents.
Magro G; Salvatorelli L; Alaggio R; D'Agata V; Nicoletti F; Di Cataldo A; Parenti R
Hum Pathol; 2017 Feb; 60():58-65. PubMed ID: 27984122
[TBL] [Abstract][Full Text] [Related]
26. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
[TBL] [Abstract][Full Text] [Related]
27.
Louati S; Senhaji N; Chbani L; Bennis S
Dis Markers; 2018; 2018():7971019. PubMed ID: 30319719
[TBL] [Abstract][Full Text] [Related]
28. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
Machado I; Navarro S; Picci P; Llombart-Bosch A
Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
[TBL] [Abstract][Full Text] [Related]
29. Meningeal Ewing Sarcoma/Peripheral PNET: Clinicopathological, Immunohistochemical and FISH study of four cases.
Ke Ch; Duan Q; Yang H; Zhu F; Yan M; Xu SP; Zhou S; Wan F; Shu K; Lei T; Xia LM
Neuropathology; 2017 Feb; 37(1):35-44. PubMed ID: 27500883
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic pitfall in the diagnosis of mesenchymal chondrosarcoma arising in the central nervous system.
Lin L; Varikatt W; Dexter M; Ng T
Neuropathology; 2012 Feb; 32(1):82-90. PubMed ID: 21615516
[TBL] [Abstract][Full Text] [Related]
31. NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls.
Russell-Goldman E; Hornick JL; Qian X; Jo VY
Cancer Cytopathol; 2018 Nov; 126(11):942-949. PubMed ID: 30376220
[TBL] [Abstract][Full Text] [Related]
32. [Clinicopathologic and immunohistochemical study of 23 cases of mesenchymal chondrosarcoma].
Pang ZG; He XZ; Wu LY; Wei W; Liu XY; Liao DY; Li FY; Zhang XL
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):368-72. PubMed ID: 21914343
[TBL] [Abstract][Full Text] [Related]
33. NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker.
Perret R; Escuriol J; Velasco V; Mayeur L; Soubeyran I; Delfour C; Aubert S; Polivka M; Karanian M; Meurgey A; Le Guellec S; Weingertner N; Hoeller S; Coindre JM; Larousserie F; Pierron G; Tirode F; Le Loarer F
Mod Pathol; 2020 Oct; 33(10):1930-1944. PubMed ID: 32327700
[TBL] [Abstract][Full Text] [Related]
34. Utility of NKX3.1 immunohistochemistry in the differential diagnosis of seminal vesicles versus prostatic tissue in needle biopsy.
Pitra T; Pivovarcikova K; Alaghehbandan R; Compérat EM; Hora M; Rogala J; Slisarenko M; Michal M; Hes O
Ann Diagn Pathol; 2020 Dec; 49():151644. PubMed ID: 33126153
[TBL] [Abstract][Full Text] [Related]
35. The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing's sarcoma family of tumors.
Vural C; Uluoğlu O; Akyürek N; Oğuz A; Karadeniz C
Pathol Oncol Res; 2011 Sep; 17(3):619-25. PubMed ID: 21267687
[TBL] [Abstract][Full Text] [Related]
36. Mesenchymal chondrosarcoma: clinicopathologic study of 20 cases.
Shakked RJ; Geller DS; Gorlick R; Dorfman HD
Arch Pathol Lab Med; 2012 Jan; 136(1):61-75. PubMed ID: 22208489
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of NKX2.2 Immunohistochemistry for Distinguishing Ewing Sarcoma from Other Sinonasal Small Round Blue Cell Tumors.
McCuiston A; Bishop JA
Head Neck Pathol; 2018 Mar; 12(1):89-94. PubMed ID: 28616785
[TBL] [Abstract][Full Text] [Related]
38. PAX7 immunohistochemical evaluation of Ewing sarcoma and other small round cell tumours.
Toki S; Wakai S; Sekimizu M; Mori T; Ichikawa H; Kawai A; Yoshida A
Histopathology; 2018 Oct; 73(4):645-652. PubMed ID: 29920735
[TBL] [Abstract][Full Text] [Related]
39. Giant primary mesenchymal chondrosarcoma of the lung: case report and review of literature.
Mei B; Lai YL; He GJ; Shou YN; Liu J
Ann Thorac Cardiovasc Surg; 2013; 19(6):481-4. PubMed ID: 23196662
[TBL] [Abstract][Full Text] [Related]
40. Application of immunohistochemistry in the diagnosis of small round blue-cell tumors of soft tissue.
Li Q; Cui W; Abulajiang G; Ma Y; Liu X; Zhang W; Li X
Clin Lab; 2014; 60(8):1383-92. PubMed ID: 25185426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]